HomeCompareARGU vs JNJ

ARGU vs JNJ: Dividend Comparison 2026

ARGU yields 19.49% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARGU wins by $50.8K in total portfolio value
10 years
ARGU
ARGU
● Live price
19.49%
Share price
$10.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$70.8K
Annual income
$6,381.75
Full ARGU calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ARGU vs JNJ

📍 ARGU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARGUJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARGU + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARGU pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARGU
Annual income on $10K today (after 15% tax)
$1,656.92/yr
After 10yr DRIP, annual income (after tax)
$5,424.49/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ARGU beats the other by $4,720.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARGU + JNJ for your $10,000?

ARGU: 50%JNJ: 50%
100% JNJ50/50100% ARGU
Portfolio after 10yr
$45.4K
Annual income
$3,604.77/yr
Blended yield
7.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ARGU
Analyst Ratings
1
Buy
Consensus: Buy
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARGU buys
0
JNJ buys
0
No recent congressional trades found for ARGU or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARGUJNJ
Forward yield19.49%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$70.8K$20.0K
Annual income after 10y$6,381.75$827.78
Total dividends collected$39.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: ARGU vs JNJ ($10,000, DRIP)

YearARGU PortfolioARGU Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,649$1,949.32$10,676$355.77+$2.0KARGU
2$15,839$2,304.44$11,407$389.39+$4.4KARGU
3$19,645$2,696.80$12,198$426.53+$7.4KARGU
4$24,146$3,125.92$13,056$467.62+$11.1KARGU
5$29,427$3,590.78$13,987$513.12+$15.4KARGU
6$35,577$4,089.84$14,998$563.56+$20.6KARGU
7$42,688$4,621.08$16,098$619.52+$26.6KARGU
8$50,858$5,182.05$17,295$681.69+$33.6KARGU
9$60,188$5,769.96$18,599$750.82+$41.6KARGU
10$70,783$6,381.75$20,022$827.78+$50.8KARGU

ARGU vs JNJ: Complete Analysis 2026

ARGUStock

Argus Capital Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the media/entertainment/sports industries. The company was incorporated in 2021 and is based in New York, New York.

Full ARGU Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ARGU vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARGU vs SCHDARGU vs JEPIARGU vs OARGU vs KOARGU vs MAINARGU vs ABBVARGU vs MRKARGU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.